StemCell InstituteStemCell Institute Inc.7096東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

What does StemCell Institute do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥73.5M
Capex
¥526.8M
of revenue 18.7%
Free cash flow
-¥453.3M
Returned to shareholders
¥106.2M
of net income: 68%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥155.9M
Operating cash flow¥73.5M
Cash conversion (operating CF ÷ operating income)
36.3%
Cash vs. profit gap
-¥82.4M(純利益の -52.9%)
Shareholder returns
of net income 68.1%
Shareholder payments — dividends
of net income 0.1%
CapEx intensity (capex ÷ revenue)
18.7%
Investing CF relative to operating CF
1012.9%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥73.5M
FY ending Mar 2022: ¥469.3M¥469.3MFY ending Mar 2023: ¥99.7M¥99.7MFY ending Mar 2024: ¥334.6M¥334.6MFY ending Mar 2025: ¥467.7M¥467.7MFY ending Mar 2026: ¥73.5M¥73.5MFY22FY23FY24FY25FY26
Free cash flow-¥453.3M
FY ending Mar 2022: ¥264.8M¥264.8MFY ending Mar 2023: ¥39.8M¥39.8MFY ending Mar 2024: ¥133M¥133MFY ending Mar 2025: -¥107.1M-¥107.1MFY ending Mar 2026: -¥453.3M-¥453.3MFY22FY23FY24FY25FY26
Net income¥155.9M
FY ending Mar 2022: ¥133.7M¥133.7MFY ending Mar 2023: ¥198M¥198MFY ending Mar 2024: ¥311M¥311MFY ending Mar 2025: ¥385.8M¥385.8MFY ending Mar 2026: ¥155.9M¥155.9MFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第27期(2025/04/01-2026/03/31)

    ID S100YI322026-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2024/04/01-2025/03/31)

    ID S100W2VG2025-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2023/04/01-2024/03/31)

    ID S100TW622024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(2022/04/01-2023/03/31)

    ID S100R2C52023-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(令和3年4月1日-令和4年3月31日)

    ID S100OD0Y2022-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(令和2年4月1日-令和3年3月31日)

    ID S100LVGX2021-06-30Open

Extracted from XBRL: 49 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.